Cell exhaustion in HIV-1 infection: Role of suppressor cells

Current Opinion in HIV and AIDS

Volumn 9, Issue 5, 2014, Pages 452-458

  Seddiki, Nabila ^a,b,c   Brezar, Vedran ^a,b,c   Draenert, Rika ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b Facultéde Médecine UniversitéParis Est ^*  (France)

^c Vaccine Research Institute   (France)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CD39; Forkhead box P3; HIV 1; myeloid derived suppressor cell; OX40; regulatory B cells; regulatory T cells

Indexed keywords

CD39 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 RECEPTOR;

ALLELE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL TRACKING; EXHAUSTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

B-LYMPHOCYTES, REGULATORY; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM PHENOMENA; T-LYMPHOCYTES, REGULATORY;

EID: 84906069774     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000087     Document Type: Review

References (57)

1. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: Causes and consequences. J Pathol 2008; 214:231-241. (Pubitemid 351160160)
2. McMurchy AN, Levings MK. Suppression assays with human T regulatory cells: A technical guide. Eur J Immunol 2012; 42:27-34.
3. Kinter AL, Hennessey M, Bell A, et al. CD25(\+)CD4(\+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(\+) and CD8(\+) HIV-1-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004; 200:331-343. (Pubitemid 39031252)
4. Weiss L, Donkova-Petrini V, Caccavelli L, et al. Human immunodeficiency virus-driven expansion of CD4\+CD25\+ regulatory T cells, which suppress HIV-1-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104:3249-3256. (Pubitemid 39507143)
5. Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood 2013; 121:29-37.
6. Schneider A, Rieck M, Sanda S, et al. The effector T cells of diabetic subjects are resistant to regulation via CD4\+ FOXP3\+ regulatory T cells. J Immunol 2008; 181:7350-7355.
7. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3\+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500.
8. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-1700. (Pubitemid 44036275)
9. Simonetta F, Bourgeois C. CD4\+FOXP3\+ regulatory T-cell subsets in human immunodeficiency virus infection. Front Immunol 2013; 4:215.
10. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007; 21:1525-1534. (Pubitemid 47075472)
11. Lim A, French MA, Price P. CD4\+ and CD8\+T cells expressing FoxP3 in HIVinfected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 51:248-257.
12. Clutton G, Yang H, Hancock G, et al. Emergence of a distinct HIV-1-specific IL-10-producing CD8\+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection. Eur J Immunol 2013; 43:2875-2885.
13. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4\+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30:899-911.
14. Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleotidase CD39 by Foxp3\+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110:1225-1232. (Pubitemid 47281420)
15. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176:4622-4631.
16. Nikolova M, Carriere M, Jenabian MA, et al. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog 2011; 7:e1002110.
17. Schulze Zur Wiesch J, Thomssen A, Hartjen P, et al. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3\+ T regulatory cells correlates with progressive disease. J Virol 2011; 85:1287-1297.
18. Moreno-Fernandez ME, Rueda CM, Rusie LK, Chougnet CA. Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 2011; 117:5372-5380.
19. Seddiki N, Cook L, Hsu DC, et al. Human antigen-specific CD4\+CD25\+ CD134\+CD39\+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses. Eur J Immunol 2014; 44:1644-1661.
20. Angin M, King M, Altfeld M, et al. Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers. AIDS 2012; 26:2112-2115.
21. Zaunders JJ, Munier ML, Seddiki N, et al. High levels of human antigenspecific CD4\+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J Immunol 2009; 183:2827-2836.
22. Lu W, Chen S, Lai C, et al. Induction of CD8\+ regulatory T cells protects macaques against SIV challenge. Cell Rep 2012; 2:1736-1746.
23. Young MR, Newby M, Wepsic HT. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res 1987; 47:100-105. (Pubitemid 17002105)
24. Greten TF, Manns MP, Korangy F. Myeloid derived suppressor cells in human diseases. Int Immunopharmacol 2012; 11:802-807.
25. Khaled YS, Ammori BJ, Elkord E. Myeloid-derived suppressor cells in cancer: Recent progress and prospects. Immunol Cell Biol 2013; 91:493-502.
26. Goh C, Narayanan S, Hahn YS. Myeloid-derived suppressor cells: The dark knight or the joker in viral infections? Immunol Rev 2013; 255:210-221.
27. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-174.
28. Dumitru CA, Moses K, Trellakis S, et al. Neutrophils and granulocytic myeloidderived suppressor cells: Immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother 2012; 61: 1155-1167.
29. Kotsakis A, Harasymczuk M, Schilling B, et al. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J ImmunolMethods 2012; 381:14-22.
30. Serafini P. Myeloid derived suppressor cells in physiological and pathological conditions: The good, the bad, and the ugly. Immunol Res 2013; 57:172-184.
31. Sander LE, Sackett SD, Dierssen U, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloidderived suppressor cell function. J Exp Med 2010; 207:1453-1464.
32. Rieber N, Brand A, Hector A, et al. Flagellin induces myeloid-derived suppressor cells: Implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 2013; 190:1276-1284.
33. Vollbrecht T, Stirner R, Tufman A, et al. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012; 26:F31-F37.
34. Qin A, Cai W, Pan T, et al. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J Virol 2013; 87:1477-1490.
35. Hoechst B, Voigtlaender T, Ormandy L, et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009; 50:799-807.
36. Cheng P, Corzo CA, Luetteke N, et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008; 205:2235-2249.
37. Garg A, Spector SA. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J Infect Dis 2014; 209:441-451.
38. Trellakis S, Bruderek K, Hutte J, et al. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer. Innate Immun 2013; 19:328-336.
39. DiLillo DJ, Horikawa M, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res 2011; 49:281-292.
40. Neta R, Salvin SB. Specific suppression of delayed hypersensitivity: The possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol 1974; 113:1716-1725.
41. Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions. Nature 1974; 251:550-551.
42. Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhiCD5\+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-650. (Pubitemid 351636247)
43. Nouel A, Simon Q, Jamin C, et al. Regulatory B cells: An exciting target for future therapeutics in transplantation. Front Immunol 2014; 5:11.
44. Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014; 507:366-370.
45. Chesneau M, Michel L, Degauque N, Brouard S. Regulatory B cells and tolerance in transplantation: From animal models to human. Front Immunol 2013; 4:497.
46. Blair PA, Norena LY, Flores-Borja F, et al. CD19(\+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus erythematosus patients. Immunity 2010; 32:129-140.
47. Lemoine S, Morva A, Youinou P, Jamin C. Human T cells induce their own regulation through activation of B cells. J Autoimmun 2011; 36:228-238.
48. Ding Q, Yeung M, Camirand G, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011; 121:3645-3656.
49. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491:264-268.
50. Majlessi L, Lo-Man R, Leclerc C. Regulatory B and T cells in infections. Microbes Infect 2008; 10:1030-1035.
51. Liu J, Zhan W, Kim CJ, et al. IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses. PLoS One 2014; 9:e89236.
52. Siewe B, Stapleton JT, Martinson J, et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8(\+) T cell function in vitro. J Leukoc Biol 2013; 93:811-818.
53. Siewe B, Wallace J, Rygielski S, et al. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS One 2014; 9:e92934.
54. Grosso JF, Jure-Kunkel MN. CTLA-4 blockade in tumor models: An overview of preclinical and translational research. Cancer Immun 2013; 13:5.
55. McDermott DF, Atkins MB. PD-1 as a potential target in cancer therapy. Cancer Med 2013; 2:662-673.
56. Seddiki N, Phetsouphanh C, Swaminathan S, et al. The microRNA-9/ Blymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection. Eur J Immunol 2013; 43:510-520.
57. Solstad T, Bains SJ, Landskron J, et al. CD147 (Basigin/Emmprin) identifies FoxP3\+CD45RO\+CTLA4\+-activated human regulatory T cells. Blood 2011; 118:5141-5151.